Dal Alert!

Receive alerts from Dalhousie by text message.

X

Deadline (extended): Weston Brain Institute's Transformational Research Program

UPDATED DECEMBER 4TH:

Weston Brain Insitute are pleased to announce that they have extended the deadline for the Transformational Research: Canada 2018 program, from December 7, 2017 to February 15, 2018 at 2:00pm EST.

If you have already started an application on the system, please continue to work on it and prepare to submit by February 15.

Details below:

Transformational Research: Canada 2018

LOI extended deadline: February 15, 2018 at 2pm EST
Award announcement:
September 2018

Program overview: Larger, longer grants (up to $1.5m for up to 3 years) for transformational work based on excellent preliminary data, including clinical studies not covered under the Early Phase Clinical Trials program below. Clinical trials or clinical trial sub-studies should be submitted to the Early-Phase Clinical Trials or Rapid Response programs.

Please contact Rene at rene.prashad@weston.ca or 416-965-5735 with any questions.

Transformational Research: Canada 2018 Neurodegenerative Diseases of Aging

NEW for 2018
1. Translational research using humans or human samples/data is in scope, except for clinical trials or clinical trial sub-studies which should be submitted to the Early-Phase Clinical Trials or Rapid Response programs.
2. The Institute has updated which tools are in scope. Please see below and read our What We Fund webpage before applying to ensure your project is in scope.

Goal: To provide funding for translational research that will accelerate the development of therapeutics for neurodegenerative diseases of aging.

Funding: A maximum of $1,500,000 over up to 3 years.

Applicant Eligibility: Eligible Principal Applicants must be researchers working in Canada at least 30% of the time at or above the level of Assistant Professor or equivalent, and be affiliated with a Canada Revenue Agency-qualified donee institution located in Canada. Co-Applicants/Collaborators must be at the post-doctoral level or above and can be working outside Canada.

Project Eligibility: Projects must meet the following conditions to be eligible:
1. Be translational research, excluding clinical trials and clinical trial sub-studies, that accelerates the development of therapeutics for neurodegenerative diseases of aging.
    o Clinical trials and clinical trial sub-studies should be submitted to the Early-Phase Clinical Trials or Rapid Response programs; however other translational research using humans or human samples/data is in scope.
2. Be the development of a therapeutic and/or tool.
3. Have excellent preliminary data to support the proposed project.

Disease Scope: All the Institute’s neurodegenerative diseases of aging are covered by this program (see What We Fund page).

Development Scope: Development of a therapeutic and/or a tool that helps to accelerate the development of therapeutics for neurodegenerative diseases of aging.

Important Dates:
Program Information Webinar: October 25th, 2017 at 1pm EDT (Register here)
Letter of Intent Deadline: December 7th, 2017 at 2pm EDT
Anticipated Award: August 2018

APPLY HERE

For more information, please see the attached Request for Applications (pdf) or visit our website. Please contact me with any questions, including whether a potential idea is in scope.

Program Announcement
The Institute’s Postdoctoral Scholars at Oxford program is now open to applicants year-round. Canadian postdoctoral researchers working in the field of translational research on neurodegenerative diseases of aging may apply to receive up to £57,000 in funding (£44,000 salary + benefits) for research performed in a host lab at the University of Oxford. Successful candidates will also be affiliated with Merton College. For more information, visit our website or contact Rachel Reeve at rachel.reeve@weston.ca.

Time